It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their U.S.

(Reuters) - President Donald Trump is facing pressure from U.S. hospitals and generic drugmakers to exempt medical goods from ...

Shares of Merck & Co. Inc. MRK slid 1.81% to $88.05 Thursday, on what proved to be an all-around mixed trading session for ...

During health secretary nominee Robert F. Kennedy Jr.'s Jan. 29 Senate confirmation hearing, Sen. Elizabeth Warren, D-Mass., ...

The waveLINE-010 trial will compare zilovertamab vedotin, in combination with rituximab plus cyclophosphamide, doxorubicin, and prednisone against the current standard-of-care in patients with ...

Robert F. Kennedy Jr.'s nomination for US health secretary advances with crucial Republican support, despite controversy over ...

Bristol Myers Squibb beat Q4 estimates with $12.34 billion revenue and $1.67 EPS. 2025 guidance lags expectations amid ...

Co., Inc. (NYSE: MRK) has initiated a pivotal Phase 3 clinical trial, waveLINE-010, to evaluate the efficacy of its investigational drug zilovertamab vedotin in treating patients with previously ...

MATERNAL DEATH RATES FALL — Fewer women died during pregnancy, childbirth and the postpartum period in 2023, but disparities in death rates between white women and women of color widened, POLITICO’s ...

Here are seven attractively valued dividend stocks investors can bet on for the long term, according to Bank of America ...

The 2025 tax season officially opened Jan. 27, when the IRS and the Vermont Department of Taxes will begin accepting personal income tax returns for tax year 2024. The 2025 filing deadline for ...

Check out the latest brokerage calls and analyst comments on the stocks in action today. Our coverage includes Bharti Airtel, ...